MRNACAUTIOUS

MRNA Return on Equity (ROE) Analysis

-39.0%

Updated 6h ago·SEC filings & market data

Key Takeaway

Return on equity (ROE) measures how much profit a company generates from shareholders' money, and a -39.0% value means MRNA is currently losing money on its equity base.

Sector Performance

5th percentile

MRNA

-39.0%

Sector Median

13.3%

Sector Avg

16.9%

Prior Period

-36.6%(Jul 2026)

↓ Declining
📊

Deep Analysis

Return on equity (ROE) measures how much profit a company generates from shareholders' money, and a -39.0% value means MRNA is currently losing money on its equity base.

That sits far below the sector median of 13.6%, placing the stock at the 4th percentile among sector peers. The year-over-year change is not available, but the quarter-over-quarter change is -6.6%, with ROE moving from -36.6% to -39.0% in the latest period. A deeply negative ROE that is also declining points to persistent shareholder value destruction and a higher risk of continued losses. This metric contradicts any optimistic outlook and directly supports the overall CAUTIOUS verdict.

Frequently Asked Questions

What does the Return on Equity (ROE) tell investors about MRNA?

ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.

How is the Return on Equity (ROE) calculated?

Return on Equity (ROE) is calculated as: Net Income / Shareholders' Equity.

Who are MRNA's closest peers by Return on Equity (ROE)?

The closest peers by Return on Equity (ROE) include: LOW (-67.1%), MAR (-69.0%), BMBL (-76.9%), WBA (-82.7%), NIO (-84.0%).

The Formula

Net Income / Shareholders' Equity

Why It Matters

ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.

Advertisement

Master MRNA's Valuation

Get the complete institutional research report covering all fundamental and technical metrics.

View full MRNA research report

Free account — no credit card

MRNA

-39.0%

Sector Median

13.3%

Sector Avg

16.9%

How MRNA's Return on Equity (ROE) compares to sector peers.

Not financial advice. Research tool only. Data may be delayed.